/Companies

Vireo Health

Minneapolis, US · Founded 2015 · Delaware corporation · 1 known investors

Find your way into Vireo Health

Sign up to see every warm intro you have to Vireo Health

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Vireo Health team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Vireo Health produces medical cannabis products organized into color-coded product lines (the Vireo Spectrum), with pharmacists recommending THC- or CBD-dominant options based on a patient's qualifying medical condition. It serves medical cannabis patients treating conditions such as chemotherapy-related nausea, epilepsy, and other neurological diseases.

Founders & leadership

Vireo Health was founded in 2015 by Kyle Kingsley.

KK
Kyle KingsleyFounder
DP
Daniel PellaExecutive
ASAmber Shimpa
Amber ShimpaExecutiveAmber Shimpa is an Executive Officer and Director at Vireo Health, a medical cannabis company founded in 2014 that develops pharmacist-guided, color-coded product lines for patients with qualifying medical conditions.
LB
Laura BultmanExecutive
AH
Aaron HoffnungNamed on SEC filing
SD
Stephen DahmerNamed on SEC filing
EG
Eric GreenbaumNamed on SEC filing

Board

BG
Brooke GehringBoard director

Investors · 1

Reported raises · per SEC filings

Form D private placements

$16.2M disclosed across 2 of 3 rounds · 2015–2020

▶$16.1MraisedAug 2018 · 61 investors · Pharmaceuticals
Rule 506(c)
Officers, directors & promoters on the filing
  • Aaron HoffnungExecutive Officer, Director
  • Amber ShimpaExecutive Officer, Director
  • Stephen DahmerExecutive Officer
  • Eric GreenbaumExecutive Officer
  • Kyle KingsleyExecutive Officer, Director, Promoter
Offering amount
$17.3M
Amount sold
$16.1M
Sales commissions
$763.8K
Placement agents
Eight Capital Corp.
First sale
Jul 2018
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06c
Full filing on SEC EDGAR ↗
▶$100KraisedJan 2016 · 1 investors · Pharmaceuticals
Rule 506(c)
Officers, directors & promoters on the filing
  • Daniel PellaExecutive Officer
  • Amber ShimpaExecutive Officer, Director
  • Kyle KingsleyExecutive Officer, Director, Promoter
  • Laura BultmanExecutive Officer, Director
  • Brooke GehringDirector
Offering amount
$31.5M
Amount sold
$100K
Minimum investment
$100K
First sale
Nov 2015
Incorporated
Limited Liability Company, Minnesota, 2015
Federal exemptions
06c
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 5

Companies working in the same space as Vireo Health.

Frequently asked questions

What does Vireo Health do?
Vireo Health produces medical cannabis products organized into color-coded product lines (the Vireo Spectrum), with pharmacists recommending THC- or CBD-dominant options based on a patient's qualifying medical condition. It serves medical cannabis patients treating conditions such as chemotherapy-related nausea, epilepsy, and other neurological diseases.
Who founded Vireo Health?
Vireo Health was founded by Kyle Kingsley in 2015.
Who are Vireo Health's investors?
Vireo Health's investors include Eight Capital.
How much funding has Vireo Health raised?
Vireo Health has disclosed $16.2M raised across 2 of its 3 known rounds.
Where is Vireo Health headquartered?
Vireo Health is headquartered in Minneapolis, US.